Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Res Regulatory News (PANR)

Share Price Information for Pantheon Res (PANR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 26.60
Bid: 26.72
Ask: 26.98
Change: 0.00 (0.00%)
Spread: 0.26 (0.973%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 26.60
PANR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Close of Capital Raising

19 Jul 2019 08:06

RNS Number : 1042G
Pantheon Resources PLC
19 July 2019
 

THIS ANNOUNCEMENT, INCLUDING THE APPENDIX, AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR AUSTRALIA, OR TO BE TRANSMITTTED OR DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (596/2014/EU) ("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

 

Capitalised terms in this Announcement shall have the meanings given to such terms in the Company's announcement of 16:58 on 18 July 2019.

 

 

19 July 2019

Pantheon Resources plc

("Pantheon" or "the Company")

 

Close of Capital Raising

 

Pantheon Resources plc (AIM:PANR), the AIM-quoted oil and gas exploration company with working interests in several conventional project areas in Tyler and Polk Counties, onshore East Texas, and onshore North Slope of Alaska, announces that the Bookbuild has been significantly oversubscribed and is now closed. Participants in the Placing will be contacted by Arden Partners to confirm their allocations. A further announcement will be made shortly confirming details of the Capital Raising.

 

The Capital Raising will raise approximately US$10.7 million (before expenses) at an issue price of 18 pence per share.

 

Jay Cheatham, CEO of Pantheon Resources, said:

 

"I am delighted with the incredible support received for this fund raising, and I am pleased to welcome some new quality institutional names to our share register. 2019 has been a tremendous year for Pantheon, starting with the successful merger with Great Bear Petroleum and followed more recently with the announcement of a significant discovery at our Alkaid/Phecda project, which we believe contains between 90 - 135 million barrels of oil P50 Technically Recoverable Resource. This fundraising will allow us to continue the permitting, engineering, geological and geophysical work necessary to plan for drilling operations this coming winter, and to position us better for farmout discussions, which I am pleased to report have already commenced. Pantheon will be seeking a significant up-front payment as well as a carried work program on future operations.

I am pleased there was excess demand for this capital raise and the price was done at a minimal discount to the close on 18 July of 2.1%."

 

Pantheon

020 7484 5361

Jay Cheatham, CEO

Justin Hondris, Director, Finance and Corporate Development

 

Arden Partners plc (Nominated Adviser and Broker)

0207 614 5950

Paul Shackleton / Dan Gee-Summons - Corporate Finance

Simon Johnson - Corporate Broker

Fraser Marshall - Equity Sales

Blytheweigh (PR)

Tim Blythe

Julia Tilley

Jane Lenton

0207 138 3204

 

 

IMPORTANT NOTICE

 

This announcement is released by Pantheon and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 ("MAR") it is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of the Company by Ben Harber, Company Secretary.

 

No action has been taken by the Company or Arden, or any of their respective affiliates, that would, or which is intended to, permit a public offer of the New Ordinary Shares in any jurisdiction or the possession or distribution of this announcement or any other offering or publicity material relating to the New Ordinary Shares in any jurisdiction where action for that purpose is required. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions. Persons into whose possession this announcement comes shall inform themselves about, and observe, such restrictions.

 

No prospectus has been made available in connection with the matters contained in this announcement and no such prospectus is required (in accordance with the Prospectus Directive (as defined below) to be published.

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS FOR INFORMATION PURPOSES ONLY, AND IS NOT INTENDED TO AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO PURCHASE OR SUBSCRIBE FOR, UNDERWRITE, SELL OR ISSUE OR THE SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE, SELL, ACQUIRE, DISPOSE OF THE NEW ORDINARY SHARES OR ANY OTHER SECURITY IN THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA, COLLECTIVELY THE "UNITED STATES"), AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR IN ANY JURISDICTION IN WHICH, OR TO ANY PERSONS TO WHOM, SUCH OFFERING, SOLICITATION OR SALE WOULD BE UNLAWFUL.

 

The New Ordinary Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or under the securities laws of any state or other jurisdiction of the United States, and may not be offered, sold or transferred, directly or indirectly, in or into the United States unless registered under the Securities Act or pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with applicable state laws. There will be no public offering of the New Ordinary Shares in the United States or elsewhere other than in the United Kingdom and certain other jurisdictions.

 

The relevant clearances have not been, and nor will they be, obtained from the securities commission of any province or territory of Canada; no prospectus has been lodged with, or registered by, the Australian Securities and Investments Commission or the Japanese Ministry of Finance; and the New Ordinary Shares have not been, and nor will they be, registered under or offered in compliance with the securities laws of any state, province or territory of Canada, Australia, Japan or South Africa. Accordingly, the New Ordinary Shares may not (unless an exemption under the relevant securities laws is applicable) be offered, sold, resold or delivered, directly or indirectly, in or into Canada, Australia, Japan or South Africa or any other jurisdiction outside the United Kingdom or to, or for the account or benefit of any national, resident or citizen of Australia, Japan or South Africa or to any investor located or resident in Canada.

 

Arden is authorised and regulated in the United Kingdom by the Financial Conduct Authority and is acting exclusively for the Company in connection with the Capital Raising and Admission and no one else and will not be responsible to anyone other than the Company for providing the protections afforded to its clients nor for providing advice to any other person in relation to the Capital Raising and Admission and/or any other matter referred to in this announcement.

 

This announcement is being issued by and is the sole responsibility of the Company. No representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by Arden (apart from the responsibilities or liabilities that may be imposed by the FSMA, as amended, or the regulatory regime established thereunder) or any of its affiliates or any of its or respective directors, officers, employees, advisers, representatives or shareholders (collectively, "Representatives") for the contents of this announcement, or any other written or oral information made available to or publicly available to any interested party or its advisers, or any other statement made or purported to be made by or on behalf of the Company or Arden or any of their respective affiliates or by any of their respective Representatives in connection with the Company, the New Ordinary Shares, the Capital Raising or Admission and any responsibility and liability whether arising in tort, contract or otherwise therefore is expressly disclaimed. Arden and its affiliates and each of their respective Representatives accordingly disclaim all and any liability, whether arising in tort, contract or otherwise (save as referred to above) in respect of any statements or other information contained in this announcement and no representation or warranty, express or implied, is made by Arden or any of its affiliates or any of their respective Representatives as to the accuracy, fairness, verification, completeness or sufficiency of the information contained in this announcement and nothing in this announcement is, or shall be relied upon as, a promise or representation in this respect, whether as to the past or future.

 

 

This announcement contains (or may contain) certain forward-looking statements, beliefs or opinions, with respect to certain of the Company's current expectations and projections about future prospects, developments, strategies, performance, anticipated events or trends and other matters that are not historical facts. These forward-looking statements, which sometimes use words such as "aim", "anticipate", "believe", "intend", "plan" "estimate", "expect" and words of similar meaning, include all matters that are not historical facts and reflect the directors' beliefs and expectations and involve a number of risks, uncertainties and assumptions that could cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statement. These statements are subject to unknown risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Statements contained in this announcement regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The information contained in this announcement is subject to change without notice and, except as required by applicable law, neither the Company nor Arden nor any of their respective affiliates nor any of their respective Representatives assumes any responsibility or obligation to update, amend or revise publicly or review any of the forward-looking statements contained in this announcement. You should not place undue reliance on forward-looking statements, which speak only as of the date of this announcement. Any indication in this announcement of the price at which New Ordinary Shares have been bought or sold in the past cannot be relied upon as a guide to future performance. No statement in this announcement is or is intended to be a profit forecast or profit estimate or to imply that the earnings of the Company for the current or future financial years will necessarily match or exceed the historical or published earnings of the Company. Past performance of the Company cannot be relied on as a guide to future performance and persons reading this announcement are cautioned not to place undue reliance on such forward-looking statements.

 

The New Ordinary Shares to be issued pursuant to the Capital Raising will not be admitted to trading on any stock exchange other than the AIM market operated by the London Stock Exchange.

 

Neither the content of the Company's website nor any website accessible by hyperlinks on the Company's website is incorporated in, or forms part of, this announcement.

 

Information for Distributors

 

Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ("MiFID II"); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the "MiFID II Product Governance Requirements"), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any "manufacturer" (for the purposes of the Product Governance Requirements) may otherwise have with respect thereto, the New Ordinary Shares have been subject to a product approval process, which has determined that such securities are: (i) compatible with an end target market of investors who meet the criteria of retail and professional clients and eligible counterparties, each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the "Target Market Assessment").

 

Notwithstanding the Target Market Assessment, distributors should note that: the price of the New Ordinary Shares may decline and investors could lose all or part of their investment; the New Ordinary Shares offer no guaranteed income and no capital protection; and an investment in New Ordinary Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessment is without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Proposals. Furthermore, it is noted that, notwithstanding the Target Market Assessment, Arden will only procure investors who meet the criteria of professional clients and eligible counterparties.

 

For the avoidance of doubt, the Target Market Assessment does not constitute: (a) an assessment of suitability or appropriateness for the purposes of MiFID II; or (b) a recommendation to any investor or Company of investors to invest in, or purchase, or take any other action whatsoever with respect to the New Ordinary Shares pursuant to the Capital Raising.

 

Each distributor is responsible for undertaking its own Target Market Assessment in respect of the New Ordinary Shares and determining appropriate distribution channels.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOESFFSWUFUSESW
Date   Source Headline
28th Mar 20247:05 amRNSProgress on Funding and Development Planning
21st Mar 202411:51 amRNSTR-1: Notification of major holdings
18th Mar 20247:00 amRNSUnaudited Interim Results
14th Mar 20247:00 amRNSQuarterly Repayment of Unsecured Convertible Bonds
5th Mar 20245:05 pmRNSResponse to Share Price Volatility
2nd Feb 20247:00 amRNSTR-1: Notification of major holdings
1st Feb 20247:00 amRNSDirector/PDMR notification
24th Jan 20243:15 pmRNSResult of AGM & Investor Presentation Details
23rd Jan 20247:00 amRNSAnnual General Meeting
2nd Jan 20247:00 amRNSTR-1: Notification of major holdings
19th Dec 20237:00 amRNSFinal Results for the Year Ended 30 June 2023
14th Dec 20237:04 amRNSSuccessful Acquisition of Leases
12th Dec 20237:00 amRNSAppointment of Independent Non-Executive Director
21st Nov 20234:36 pmRNSStrategy Update
15th Nov 20231:54 pmRNSInvestor Presentation via Investor Meet Company
14th Nov 202311:56 amRNSBond Payment, Placement & Corporate Update
19th Oct 20237:00 amRNSValidation of frac design and fluid sampling
18th Oct 20237:00 amRNSPantheon Presenting at OTC Oil and Gas Conference
4th Oct 20237:00 amRNSReplacement TR-1: Notification of major holdings
3rd Oct 20234:02 pmRNSTR-1: Notification of major holdings
27th Sep 20237:00 amRNSCommencement of Operations - Re-entry of Alkaid-2
14th Sep 20233:34 pmRNSWebinar and update
8th Sep 20238:20 amRNSInvestor Presentation Webinar
7th Sep 20237:00 amRNSPrivate Placement
30th Aug 20237:00 amRNSDirector/PDMR Notification
29th Aug 20237:00 amRNSExpert Report Confirms Estimate for Kodiak Field
28th Jul 20237:57 amRNSReplacement Operational Update
28th Jul 20237:00 amRNSOperational Update
14th Jul 20239:30 amRNSInvestor Presentation via Investor Meet Company
10th Jul 20237:00 amRNSInvestor Presentation via Investor Meet Company
3rd Jul 20238:53 amRNSAppointment of Independent Non-Executive Director
28th Jun 20234:58 pmRNSWebinar and Strategy Update
26th Jun 202312:54 pmRNSUpcoming Webinar - Registration Details
15th Jun 20233:50 pmRNSIssue of Equity and Total Voting Rights
8th Jun 20237:00 amRNSAppointment of Executive Chairman
1st Jun 20237:00 amRNSLease Award
23rd May 20234:32 pmRNSUpdate on Fundraise
18th May 20235:40 pmRNSBlock Listing Six Monthly return
17th May 20237:00 amRNSResult of Capital Raise
16th May 20235:07 pmRNSRetail Offer via PrimaryBid
16th May 20234:59 pmRNSProposed Placing and Subscription
21st Apr 20237:00 amRNSOperational and corporate update
31st Mar 20237:00 amRNSUnaudited Interim Results
22nd Mar 20235:09 pmRNSResult of AGM
20th Mar 20234:45 pmRNSAGM update
20th Mar 20237:00 amRNSAGM webinar & corporate update
16th Mar 20232:08 pmRNSUpcoming Webinar – Registration Details
13th Mar 20233:33 pmRNSQuarterly Repayment of Unsecured Convertible Bonds
9th Mar 202312:17 pmRNSAppointment of Independent Non-Executive Director
6th Mar 20237:00 amRNSOperational and corporate update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.